Calliditas Therapeutics AB (publ) (STO: CALTX)
Sweden
· Delayed Price · Currency is SEK
206.80
+0.20 (0.10%)
Aug 30, 2024, 5:29 PM CET
CALTX Revenue
Calliditas Therapeutics AB had revenue of 559.78M SEK in the quarter ending June 30, 2024, with 107.80% growth. This brings the company's revenue in the last twelve months to 1.60B, up 39.27% year-over-year. In the year 2023, Calliditas Therapeutics AB had annual revenue of 1.21B with 50.32% growth.
Revenue (ttm)
1.60B
Revenue Growth
+39.27%
P/S Ratio
6.93
Revenue / Employee
7.21M
Employees
222
Market Cap
11.17B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
Swedish Orphan Biovitrum AB (publ) | 23.71B |
Getinge AB (publ) | 33.33B |
Sectra AB (publ) | 3.04B |
Camurus AB (publ) | 1.59B |
Vitrolife AB (publ) | 3.54B |
Medicover AB (publ) | 21.70B |
Elekta AB (publ) | 18.12B |
Calliditas Therapeutics AB News
- 18 days ago - Q2 2024 Calliditas Therapeutics AB Earnings Call Transcript - GuruFocus
- 19 days ago - Calliditas Therapeutics AB (publ) (CALT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Calliditas Therapeutics AB (publ) (CALT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Calliditas Therapeutics GAAP EPS of -SEK 5.47, revenue of SEK 855.3M - Seeking Alpha
- 19 days ago - Calliditas Therapeutics GAAP EPS of -SEK 5.47, revenue of SEK 855.3M - Seeking Alpha
- 19 days ago - Calliditas Therapeutics GAAP EPS of -$0.88, revenue of $559.8M - Seeking Alpha
- 19 days ago - Calliditas Therapeutics GAAP EPS of -$0.88, revenue of $559.8M - Seeking Alpha
- 20 days ago - Calliditas Interim Report January to June 2024 - PRNewsWire